CClinicalTrials.gg
CompletedNCT05583994OPTIM-PARKIIUpdated May 1, 2023

Optimising Community Resources and Support to Enhance Living With Parkinson's Disease

An interventional study of Optim Park Intervention in Parkinson Disease, sponsored by University of Southampton. Completed at 4 sites in 2 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-05-01.

Sponsored by University of Southampton · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
264
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This is a multi-centre, single-blinded, randomized, controlled trial for PwPD (people with Parkinson's Disease) to compare (i) OPTIM-PARK II (a novel personalized treatment based on the latest published research evidence and results from our extensive development work undertaken in OPTIM-PARK I) and routine care with (ii) routine care alone. The research team will provide a personalized list of available resources to the routine care arm at the end of the trial. The trial aims to recruit 60 PwPD and their carers (n=60) in the UK. This trial took place in 4 countries (Denmark, Norway, Spain and UK) but only Spain and UK included control groups, data collection in these two countries started in October 2022, after the iterative phase of the trial.

At the screening visit participants will be asked whether they would also be willing to take part in an additional qualitative study. A subgroup of participants will be selected from those that have indicated a willingness to take part in the qualitative study. Also, at the screening visit participants will be asked whether they have a carer. Having a carer is not a pre-requisite for PwPD being recruited into the trial. It is likely that some PwPD in the trial may not have a suitable carer. Where one is available, they will be invited to join the trial: if there is more than one, the main family carer, as identified by the PwPD, will be approached.

Read the detailed description

This is a multi-centre, single-blinded, randomised, controlled trial for PwPD to compare (i) OPTIM-PARK II (a novel personalised treatment based on the latest published research evidence and results from our extensive development work undertaken in OPTIM-PARK I) and routine care with (ii) routine care alone. The research team will provide a personalised list of available resources to the routine care arm at the end of the trial. The trial aims to recruit 60 PwPD and their carers (n=60) in the UK. This trial took place in 4 countries (Denmark, Norway, Spain and UK) but only Spain and UK included control groups, data collection in these two countries started in October 2022, after the iterative phase of the trial.

Participants allocated to the control group will received usual care and participants in the intervention group the Optim Park intervention.

This intervention will consist of the following:

First consultation with PwPD and carer "entrance" at point of entry to the study

The initial consultation with the PwPD and the carer will be a face-to-face consultation in the participants own home or at the clinic/primary care centre/community hub based on participants preference.

This consultation will include steps which are detailed below.

Step 1. Welcome and clarification of expectations PwPD and their carer will be welcomed to the Optim-Park II intervention. In this step, the coordinator and the PwPD and the carer will get to know each other and the clarification of expectations for this intervention will take place. The coordinator will outline that the consultation is intended to allow participants to gain information about available public and private services, community and volunteer-based resources that are available to them. In this step, the coordinator will record the resources that the PwPD and carer have already accessed or used in the past and will record this in the resource log.

Step 2. Personalised assessment and needs clarification A personalised assessment will be carried out with PwPD and carers in collaboration with the coordinator to explore and identify their needs.

For PwPD To enable this process, the PwPD and the coordinator will have access to the Living with long term conditions scale (completed during the baseline assessment) which they can use as a conversation starter to encourage PwPD to reflect on their experience of living with PD. The coordinator might also use the map of resources for clarification of needs.

For carers The carer and the coordinator will have access use the Carer Support Needs Assessment Tool (CSNAT) (completed during the baseline assessment) which they can use as a conversation starter to explore in which areas the carer require support to enable them to care for the PwPD and to preserve their own health and well-being within their caregiving role. The coordinator might also use the map of resources for clarification of needs.

Step 3. Choice of focus Based on the personalised assessment and needs clarification the coordinator, in collaboration with the PwPD and the carer, will identify the main 3 issues/areas they each want to address or need the most help and support. The coordinator will document each of their 3 issues using the Log of resources. This way the coordinators and PwPD and the carer can revisit this in the following consultations.

Step 4. Information selection Together the coordinator, PwPD and carer will decide about what resources would like to be informed about or referred to in order to tackle the main issues/areas identified in Step 2. The coordinator will in collaboration with the PwPD and carer identify which resources could best address accommodate their issues/areas of focus. Together the coordinator, the PwPD and the carer will select resources from the map of resources that are considered appropriate and acceptable for the PwPD and the carer. The coordinator will use the Log of resources to help the PwPD and the carer identify and record what were chosen to be most beneficial to their current situation and according to their expressed needs.

Step 5. Enable use of resources The coordinator will inform the PwPD and their carer about the resources and professional services available that they have selected in the previous step, and about how to access those resources/services. The coordinator will provide clear and concise information and not use technical language and outline potential individual benefits that the PwPD and carer could achieve and how this might support addressing the problems identified in step 2.

The Coordinator will use the Map of Resources to inform the PwPD and carer of the resource options available in their area. The information provided by the Coordinator may be complemented with the delivery of printed or digital material (eg: web pages; and a copy of the Map of Resources in a version designed for PwPD and carer).

The Coordinator will use the Log to record the information they have provided to PwPD and carer about community resources and professional services.

The main objective of this step is that PwPD and carers are informed so that they can use the resources as and when they want to access them. In addition, referrals, signposting and first contact can also be made in this step based on the personalized assessment of needs.

Step 6. Intervention Follow-ups The Coordinator in collaboration with PwPD and carers can decide and make the next appointment depending on when and how the next follow-up consultation will take place. It is recommended to specify the day, time and place of the next consultation before ending the initial consultation. The PwPD and their carer will be informed that they can contact the coordinator with any problems and queries via phone or email at any point without having to make another appointment.

Second consultation: Intervention "as needed" This second consultation will be initiated by the coordinator if they have not heard back from the PwPD by phone in the middle of the 3-month follow-up.

The coordinator will ask the PwPD and carer about any thoughts and progress made or problems encountered following their discussion in the previous consultation. In particular, the coordinator might ask about the three problems identified in the initial consultation and doubts or uncertainties that have arisen after their initial consultation.

If the PwPD and carer have not found the identified resources useful or helpful, the coordinator will offer to inform them of other or different resources. If the PwPD or carer are struggling to make the first contact or engaging with available resources, the coordinator will offer to support the participants. At the end of this phone call consultation, the coordinator in collaboration with PwPD and carers will decide on the date, place and time of the next and last consultation.

Third consultation: Intervention exit This third and final consultation will be face-to-face in the participants own home or at the clinic/primary care centre, by phone or digital, based on participant preference 3 months after entry to the intervention.

The coordinator will ask the PwPD and Carer about their progress made in dealing with the main 3 problems identified during the initial consultations. The coordinator will record which resources were accessed, continued or discontinued and record how useful participants found these resources in relation to addressing the main 3 problems identified.

At the end of the meeting, the coordinator will answer any final questions and ensure that participants have a copy of the map of local resources.

02

Conditions studied

  • Parkinson Disease

Browse trials for

Keywords

  • community
  • Parkinson's Disease
  • Carers
03

In context

Parkinson Disease

4,487 studies on the registry are indexed under Parkinson Disease; 1,082 are open to participants now.

This study's enrollment of 264 is above the median of 40 across 3,294 interventional studies indexed under Parkinson Disease.

Browse Parkinson Disease studies →

Lead sponsor

University of Southampton is the lead sponsor of 121 studies on the registry; 19 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • PwPD are eligible to be included in the trial if they meet the following criteria:

    1. Have a confirmed Consultant's diagnosis of Parkinson's disease.
    2. Live at home.
    3. Able to give informed consent.
    4. Able to understand and follow commands.
    5. Willing to take part in the Optim Park II intervention.

Carers of PwPD are eligible to be included in the trial if they meet the following criteria:

  1. The PwPD they are caring for has given informed consent.
  2. Live at home.
  3. Able to give informed consent.
  4. Able to understand and follow commands.
  5. Willing to take part in the Optim Park II intervention.

Exclusion criteria

Exclusion Criteria:

  • Participants who are currently hospitalised or acutely unwell will not be eligible to being included in the trial.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
264 participants (actual)

Study arms

  • No intervention
    Usual care ( control)

    All participants in the trial will continue with their usual care as deemed appropriate by health care providers, this will usually comprise attendance at medical clinics, medication, and visits from PD nurse specialists. Participants may attend group activities or access resources as part of their usual care, though from experience such sessions are rarely intensive or prolonged. Participants will be asked to record their usual care and encouraged to avoid changing that practice unless specifically requested by a health care worker during the time they are participating in the trial.

  • Experimental
    Optim Park Intervention

    A central component of the Optim-Park II intervention is to offer a single point of contact with a coordinator (appointed for the purpose of delivering the Optim-Park II intervention) to assess participants needs, have a discussion with participants to identify 3 main problems/targets PwPD and carers would most like to address based on their needs and then link up and refer participants to available community resources. The coordinators will deliver the Optim-Park intervention for PwPD and their carers in three consultations: a consultation after the baseline assessment and randomization has been undertaken at the point of "entrance" to the study; a consultation in the middle of this period; and a follow-up consultation at "exit" at 3 months. Each consultation can last between 30 min and up to 2 hours. Each consultation can be with the pair of PwPD and carer or if appropriate, separately.

    Other: Optim Park Intervention

Interventions

  • OtherOptim Park Intervention

    For participants receiving the Optim-Park II intervention, the aim is to enhance the process of living with Parkinson's Disease for the person with PD and the family-carer by building a multisectoral care pathway, with a special focus on how to optimize the use of resources and systems of support in the community in disadvantaged populations in UK.

06

What researchers measure

Primary outcomes

  1. Resources used in the community (assessing change)

    Resources identified and used as recorded in the Resource log (by the coordinator) and in the resource log diary (by patients and carers)

    Time frame: Completed at baseline and 3 months post randomisation follow-up assessment

Secondary outcomes

  1. Parkinson Disease Quality of Life 39 questionnaire (assessing change)

    Quality of Life Person with Parkinson Disease (0-100) (lower scores better Quality of Life)

    Time frame: Completed at baseline and 3 months post randomisation follow-up assessment

  2. Parkinson Disease quality of life Carer Scale (assessing change)

    Quality of Life Carer (0-100) (lower scores better Quality of Life)

    Time frame: Completed at baseline and 3 months post randomisation follow-up assessment

  3. Caregiver Burden Scale (assessing change)

    Caregiver Burden (0-84) (higher scores indicate more burden)

    Time frame: Completed at baseline and 3 months post randomisation follow-up assessment

  4. Duke University of Carolina Social support Questionnaire (assessing change)

    Social support (1-5 average score) (higher scores meaning better social support)

    Time frame: Completed at baseline and 3 months post randomisation follow-up assessment

  5. Health and social care resource use sheet (assessing change)

    Economic analysis

    Time frame: Completed at baseline and 3 months post randomisation follow-up assessment

  6. Euro Quality of Life 5 Dimension (assessing change)

    Economic analysis (1-15 individual questions (1 best posible score) and Visual Analogue Scale (0-100, 100 best health possible)

    Time frame: Completed at baseline and 3 months post randomisation follow-up assessment

07

Study locations

4 sites
  • Hospital Universitario la Princesa, Madrid, Spain
    Madrid, 28006, Spain
  • Autonomous University of Madrid/Nursing Department
    Madrid, 28029, Spain
  • Salisbury NHS Foundation Trust
    Salisbury, Hampshire SP28BJ, United Kingdom
  • University of Southampton
    Southampton, Hampshire SO17 1BJ, United Kingdom
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 1, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05583994
Lead sponsor
University of Southampton
Collaborators
Solent NHS Trust, Salisbury NHS Foundation Trust
Responsible party
Sponsor
First posted
Oct 18, 2022
Start date
Jul 13, 2022
Primary completion
Mar 31, 2023
Completion
Mar 31, 2023
Last update
May 1, 2023

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion